What is Notable?
Headquartered in San Mateo, California, Notable operates as a sophisticated automation platform specifically engineered for the healthcare industry. The company utilizes intelligent software to automate manual tasks, thereby reducing the administrative burden on healthcare providers and improving patient outcomes. By integrating seamlessly with existing electronic health record systems, Notable enables organizations to digitize and optimize patient intake, scheduling, and clinical documentation. This market position is critical, as the healthcare sector continues to prioritize digital transformation to combat rising operational costs and staffing shortages.
How much funding has Notable raised?
Notable has raised a total of $116.5M across 3 funding rounds:
Angel/Seed
$3M
Series A
$13.5M
Series B
$100M
Angel/Seed (2018): $3M with participation from Greylock Partners, Maverick Ventures, and 8VC
Series A (2018): $13.5M led by F-Prime Capital Partners, Greylock Partners, Oak HC/FT, and Maverick Ventures
Series B (2021): $100M supported by F-Prime Capital Partners, Greylock Partners, ICONIQ Growth, and Oak HC/FT
Key Investors in Notable
ICONIQ Growth
ICONIQ Growth partners with exceptional entrepreneurs and leaders who drive global impact and change, leveraging a vibrant ecosystem of founders to amplify the success of their portfolio companies from early growth stage to IPO.
Greylock Partners
As one of the oldest U.S. venture capital firms, Greylock focuses on early-stage technology companies in sectors such as enterprise software and AI, having backed market-defining businesses including Airbnb and LinkedIn.
F-Prime Capital Partners
F-Prime Capital provides a team of investors, engineers, doctors, and scientists dedicated to investing in health care and technology, leveraging deep domain expertise to support their portfolio companies.
What's next for Notable?
With the infusion of capital from its latest funding round, Notable is well-positioned to accelerate its product roadmap and expand its footprint within the enterprise healthcare market. The strategic focus will likely center on deepening its AI capabilities to handle more complex clinical workflows and expanding its reach to larger health systems. As the company matures, the emphasis will shift toward sustaining its competitive advantage through platform scalability and the continued integration of its automation suite into the broader health-tech ecosystem. Investors remain focused on the company's ability to deliver measurable ROI for its hospital and clinic partners, which will be a key indicator of its long-term viability and potential for future market dominance.
See full Notable company page
